Efficacy and safety of sirolimus and everolimus in heart transplant patients: a retrospective analysis (Q45281387)

11 December 2017

Efficacy and safety of sirolimus and everolimus in heart transplant patients: a retrospective analysis (English)

1 reference

11 December 2017

1 reference

B Baur

1

1 reference

11 December 2017

M Oroszlan

2

1 reference

11 December 2017

O Hess

3

1 reference

11 December 2017

T Carrel

4

1 reference

11 December 2017

P Mohacsi

5

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 June 2011

1 reference

Transplantation Proceedings

11 December 2017

1 reference

11 December 2017

43

1 reference

11 December 2017

5

1 reference

11 December 2017

1853-1861

1 reference

Recent trends in early outcome of adult patients after heart transplantation: a single-institution review of 251 transplants using standard donor organs.

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Mortality rates after heart transplantation: how to compare center-specific outcome data?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Seventeen-year experience with 1,083 heart transplants at a single institution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report--2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Hypertension in heart and heart-lung transplanted children: does impaired baroreceptor function play a role?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Rapamycin: a novel immunosuppressive macrolide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Role of siroliumus, a novel immunosuppressive drug in heart and lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Review of the proliferation inhibitor everolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

First experience with rapamycin-based immunosuppression to improve kidney function after heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report--2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

mTOR inhibitors and their secondary effects in cardiac transplant recipients: a descriptive study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Rapamycin: clinical results and future opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Lipid metabolism in renal transplant patients receiving tacrolimus/sirolimus combination therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

Tolerance profile of the proliferation signal inhibitors everolimus and sirolimus in heart transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.174

10.1016/J.TRANSPROCEED.2011.01.174

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference